These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The toxicology of heparin reversal with protamine: past, present and future. Sokolowska E; Kalaska B; Miklosz J; Mogielnicki A Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):897-909. PubMed ID: 27223896 [TBL] [Abstract][Full Text] [Related]
10. Reversal of post-reperfusion coagulopathy by protamine sulphate in orthotopic liver transplantation. Bayly PJ; Thick M Br J Anaesth; 1994 Dec; 73(6):840-2. PubMed ID: 7880678 [TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR. Al-Kassou B; Kandt J; Lohde L; Shamekhi J; Sedaghat A; Tabata N; Weber M; Sugiura A; Fimmers R; Werner N; Grube E; Treede H; Nickenig G; Sinning JM JACC Cardiovasc Interv; 2020 Jun; 13(12):1471-1480. PubMed ID: 32553337 [TBL] [Abstract][Full Text] [Related]
12. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass. Akl BF; Vargas GM; Neal J; Robillard J; Kelly P J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393 [TBL] [Abstract][Full Text] [Related]
13. Antagonism of SR 90107A/Org 31540-induced bleeding by protamine sulfate in rats and mice. Bernat A; Hoffmann P; Herbert JM Thromb Haemost; 1996 Nov; 76(5):715-9. PubMed ID: 8950779 [TBL] [Abstract][Full Text] [Related]
14. Heparin rebound: a comparative study of protamine chloride and protamine sulfate in patients undergoing coronary artery bypass surgery. Kuitunen AH; Salmenperä MT; Heinonen J; Rasi VP; Myllylä G J Cardiothorac Vasc Anesth; 1991 Jun; 5(3):221-6. PubMed ID: 1863741 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Bleeding Diathesis Associated with a Heparin-Like Anticoagulant in Plasma Cell Neoplasia Using Protamine. Willner CA; Chisti MM Case Rep Hematol; 2018; 2018():4342301. PubMed ID: 30009062 [TBL] [Abstract][Full Text] [Related]
16. Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation. Massonnet-Castel S; Pelissier E; Bara L; Terrier E; Abry B; Guibourt P; Swanson J; Jaulmes B; Carpentier A; Samama M Haemostasis; 1986; 16(2):139-46. PubMed ID: 3710291 [TBL] [Abstract][Full Text] [Related]
17. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass. Kunz SA; Miles LF; Ianno DJ; Mirowska-Allen KL; Matalanis G; Bellomo R; Seevanayagam S Perfusion; 2018 Sep; 33(6):445-452. PubMed ID: 29544405 [TBL] [Abstract][Full Text] [Related]
18. Use of the activated coagulation time in cardiac surgery. Effects on heparin-protamine dosages and bleeding. Papaconstantinou C; Rådegran K Scand J Thorac Cardiovasc Surg; 1981; 15(2):213-5. PubMed ID: 7336191 [TBL] [Abstract][Full Text] [Related]
19. Reversal of Anticoagulation and Management of Bleeding in Patients on Anticoagulants. Dhakal P; Rayamajhi S; Verma V; Gundabolu K; Bhatt VR Clin Appl Thromb Hemost; 2017 Jul; 23(5):410-415. PubMed ID: 27789605 [TBL] [Abstract][Full Text] [Related]